Atsushi Enomoto

14.0k total citations · 2 hit papers
195 papers, 9.9k citations indexed

About

Atsushi Enomoto is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Atsushi Enomoto has authored 195 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 61 papers in Oncology and 24 papers in Cell Biology. Recurrent topics in Atsushi Enomoto's work include Cancer Cells and Metastasis (28 papers), Wnt/β-catenin signaling in development and cancer (16 papers) and Drug Transport and Resistance Mechanisms (16 papers). Atsushi Enomoto is often cited by papers focused on Cancer Cells and Metastasis (28 papers), Wnt/β-catenin signaling in development and cancer (16 papers) and Drug Transport and Resistance Mechanisms (16 papers). Atsushi Enomoto collaborates with scholars based in Japan, United States and China. Atsushi Enomoto's co-authors include Masahide Takahashi, Hitoshi Endou, Toshimitsu Niwa, Naoya Asai, Michio Takeda, Kimiyoshi Ichida, Yoshiki Murakumo, Ping Jiang, Seok Ho and Makoto Hosoyamada and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Atsushi Enomoto

190 papers receiving 9.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular identification of a renal urate–anion exchanger that regulates blood urate levels

2002 1.1k citations Atsushi Enomoto et al. profile →
Cancer-associated fibroblasts in gastrointestinal cancer

2019 427 citations Hiroki Kobayashi, Atsushi Enomoto et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Atsushi Enomoto Japan	54	4.1k	2.6k	2.6k	1.1k	1.0k	195	9.9k
Shougang Zhuang United States	53	4.8k 1.2×	867 0.3×	2.4k 0.9×	960 0.8×	857 0.8×	213	9.0k
Hermann-Josef Gröne Germany	62	5.0k 1.2×	1.3k 0.5×	1.7k 0.7×	1.2k 1.1×	512 0.5×	170	11.9k
Taiji Matsusaka Japan	43	2.9k 0.7×	1.1k 0.4×	1.9k 0.7×	643 0.6×	607 0.6×	124	7.4k
George F. Schreiner United States	56	4.2k 1.0×	759 0.3×	3.1k 1.2×	1.2k 1.0×	1.2k 1.1×	139	11.3k
Manjeri A. Venkatachalam United States	51	4.5k 1.1×	564 0.2×	3.1k 1.2×	984 0.9×	1.0k 1.0×	116	9.6k
Yashpal S. Kanwar United States	59	6.3k 1.5×	675 0.3×	3.7k 1.4×	1.6k 1.4×	882 0.9×	234	13.8k
Youfei Guan China	60	4.4k 1.1×	742 0.3×	1.2k 0.5×	1.6k 1.4×	502 0.5×	226	10.3k
Tobias B. Huber Germany	56	5.7k 1.4×	653 0.2×	5.2k 2.0×	1.4k 1.2×	1.1k 1.1×	257	12.7k
Andreas Linkermann Germany	54	9.2k 2.2×	1.4k 0.5×	1.6k 0.6×	1.0k 0.9×	895 0.9×	104	14.7k
Volker H. Haase United States	60	6.4k 1.5×	1.2k 0.5×	1.6k 0.6×	1.2k 1.0×	531 0.5×	114	14.9k

Countries citing papers authored by Atsushi Enomoto

Since Specialization

Citations

This map shows the geographic impact of Atsushi Enomoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Enomoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Enomoto more than expected).

Fields of papers citing papers by Atsushi Enomoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Enomoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Enomoto. The network helps show where Atsushi Enomoto may publish in the future.

Co-authorship network of co-authors of Atsushi Enomoto

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Enomoto. A scholar is included among the top collaborators of Atsushi Enomoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Enomoto. Atsushi Enomoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ishihara, Seiichiro, Atsushi Enomoto, Akihiro Sakai, et al.. (2025). Stiff extracellular matrix activates the transcription factor ATF5 to promote the proliferation of cancer cells. iScience. 28(3). 112057–112057. 3 indexed citations

Wang, Xingxing, Keiko Shinjo, Reo Maruyama, et al.. (2025). Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer. British Journal of Cancer. 134(4). 577–588.

Hirasaki, Masataka, Tomoaki Torigoe, Tomonori Kawasaki, et al.. (2024). Pulmonary metastases of a renal angiomyolipoma: A case report, with whole-exome sequencing analysis. SHILAP Revista de lepidopterología. 19(11). 4963–4969.

Ishihara, Toshikazu, Katsuhiro Kato, Miyako Tanaka, et al.. (2024). Meflin/ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosis. Genes to Cells. 29(10). 902–920. 2 indexed citations

Kato, Katsuhiro, Yoshimitsu Yura, Atsushi Enomoto, et al.. (2024). Protein kinase N promotes cardiac fibrosis in heart failure by fibroblast-to-myofibroblast conversion. Nature Communications. 15(1). 7638–7638. 6 indexed citations

Li, Yu, Teruaki Fujishita, Emi Mishiro‐Sato, et al.. (2023). TGF‐β signaling promotes desmoid tumor formation via CSRP2 upregulation. Cancer Science. 115(2). 401–411. 3 indexed citations

Yamamoto, Kenta, Takashi Honda, Asuka Kato, et al.. (2023). Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis. Hepatology International. 17(6). 1378–1392. 3 indexed citations

Miyai, Yuki, Daisuke Sugiyama, Tetsunari Hase, et al.. (2022). Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade. Life Science Alliance. 5(6). e202101230–e202101230. 34 indexed citations

Hiraiwa, Hiroaki, Ryota Morimoto, Ryota Ando, et al.. (2022). Recurrent fulminant non-rheumatic streptococcal myocarditis proven by endomyocardial biopsy and autopsy. Journal of Cardiology Cases. 26(1). 62–65. 9 indexed citations

10.

Mizutani, Yasuyuki, Tadashi Iida, Eizaburo Ohno, et al.. (2022). Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma. BMC Cancer. 22(1). 24 indexed citations

11.

Suzuki, Atsushi, Koji Sakamoto, Yoshio Nakahara, et al.. (2022). BMP3b is a Novel Antifibrotic Molecule Regulated by Meflin in Lung Fibroblasts. American Journal of Respiratory Cell and Molecular Biology. 67(4). 446–458. 7 indexed citations

12.

Ichinose, Mari, Nobumi Suzuki, Tongtong Wang, et al.. (2021). The BMP antagonist gremlin 1 contributes to the development of cortical excitatory neurons, motor balance and fear responses. Development. 148(14). 5 indexed citations

13.

Sakurai, Yasutaka, Masaaki Ichinoe, Takuya Kato, et al.. (2021). CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 480(4). 819–829. 1 indexed citations

14.

Linh, Nguyễn Quang, Takeru Hamashima, Yoko Ishii, et al.. (2020). Vascular PDGFR-alpha protects against BBB dysfunction after stroke in mice. Angiogenesis. 24(1). 35–46. 39 indexed citations

15.

Yamamura, Yumiko, Naoya Asai, Atsushi Enomoto, et al.. (2015). Akt–Girdin Signaling in Cancer-Associated Fibroblasts Contributes to Tumor Progression. Cancer Research. 75(5). 813–823. 100 indexed citations

16.

Weng, Liang, Atsushi Enomoto, Hiroshi Miyoshi, et al.. (2014). Regulation of cargo‐selective endocytosis by dynamin 2 GTP ase‐activating protein girdin. The EMBO Journal. 33(18). 2098–2112. 31 indexed citations

17.

Nakamura, Nobuhisa, Keiko Naruse, Yasuko Kobayashi, et al.. (2011). High glucose impairs the proliferation and increases the apoptosis of endothelial progenitor cells by suppression of Akt. Journal of Diabetes Investigation. 2(4). 262–270. 19 indexed citations

18.

Kato, Takuya, Yohei Shimono, Masaki Hasegawa, et al.. (2009). Characterization of the HDAC1 Complex That Regulates the Sensitivity of Cancer Cells to Oxidative Stress. Cancer Research. 69(8). 3597–3604. 53 indexed citations

19.

Jiang, Ping, Atsushi Enomoto, Mayumi Jijiwa, et al.. (2008). An Actin-Binding Protein Girdin Regulates the Motility of Breast Cancer Cells. Cancer Research. 68(5). 1310–1318. 144 indexed citations

20.

Kang, Yun Hee, Kazuya Hirano, Norio Suzuki, et al.. (2000). Increased Expression after X‐Irradiation of MUC1 in Cultured Human Colon Carcinoma HT‐29 Cells. Japanese Journal of Cancer Research. 91(3). 324–330. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact